Skip to main content
. 2017 Feb 24;8(17):27839–27853. doi: 10.18632/oncotarget.15711

Figure 6. Survival of DLEU1-KD and GFP-DLEU1 mice treated with rituximab, cyclophosphamide and rituximab/cyclophosphamide combination.

Figure 6

(AD) Pair-wise comparison of survival curves of WT and DLEU1-KD mice (A–D) following the treatment of RTX, CTX, or RTX/CTX. *p < 0.05; **p < 0.005. (EH) Pair-wise comparison of control (GFP) and DLEU1 overexpressed (GFP-DLEU1) xenograft mice (E–H) following the treatment of RTX, CTX, or RTX/CTX. ns, not significant; *p < 0.05; **p < 0.005; ***p < 0.0001.